2MAR K, The clinical development of omnic (tamsulosin)controlled absorption system (OCAS1)[J]. European Urology Supplements, 2005, (4): 5-9.
3NIIGATA K, FUJIKURA T. Sulfamoyl-substituted Phenethylamine Derivatives with α-adrenergic Blocking Activity for Use as Antihypertensives and Their Pharmaceutical Compositions[P]. EP: 34432A, 1988-03-15.
4NIIGATA K, FUJIKURA T. Preparation of (Phenoxyethylamino)Propylbenzenesulfonamide Derivatives as α-blockers[P]. JP: 62/ 114952, 1987-05-26.
5OKADA M, YOSHIDA K, TAKANOBU K. Process for Producing Optically Active m-(aminoalkyl)benzenesulfonamide Derivatives Useful as Antihypotensives and as Drug Intermediates[P]. EP:257787, 1988-03-02.
6BORUT F, ANTON C, BORUT F, et al. Preparation of R-S(2-(2-ethoxyphenoxyethylamino)propyl) -2-methoxybenzenesulphonamide Hydroehloride of High Chemical[P]. WO: 2005063702, 2005-07-14.
7DANIELA A, ELISABETTA B, CLAUDIO F. A new enzymatic approach to (R)-tamsulosin hydrochloride[J]. Tetrahedronz Asymmetry, 2007,18:488-492.
